p53 and NF-κB: Different strategies for responding to stress lead to a functional antagonism

FASEB Journal

Volumn 24, Issue 10, 2010, Pages 3643-3652

  Ak, Prashanth ^a   Levine, Arnold J ^a  

^a INSTITUTE FOR ADVANCED STUDY   (United States)

Author keywords

Aerobic glycolysis; O GlcNAc; Oncogene; Oxidative phosphorylation; Pathway nodes; Signal transduction; Tumor suppressor gene

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P53;

CELL CYCLE ARREST; CELL DIVISION; CELL SURVIVAL; DNA SEQUENCE; GENE EXPRESSION; METABOLIC REGULATION; MISSENSE MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; STRESS; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PHYSIOLOGY;

NF-KAPPA B; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77957850069     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-160549     Document Type: Review

References (61)

1. Campbell, K. J., Rocha, S., and Perkins, N. D. (2004) Active repression of antiapoptotic gene expression by RelA(p65) NFkappa B. Mol. Cell 13, 853-865
2. Ryan, K. M., Ernst, M. K., Rice, N. R., and Vousden, K. H. (2000) Role of NF-kappaB in p53-mediated programmed cell death. Nature 404, 892-897
3. Minamino, T., Orimo, M., Shimizu, I., Kunieda, T., Yokoyama, M., Ito, T., Nojima, A., Nabetani, A., Oike, Y., Matsubara, H., Ishikawa, F., and Komuro, I. (2009) A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat. Med. 15, 1082-1087
4. Wang, T., Marquardt, C., and Foker, J. (1976) Aerobic glycolysis during lymphocyte proliferation. Nature 261, 702-705
5. Marine, J. C., Francoz, S., Maetens, M., Wahl, G., Toledo, F., and Lozano, G. (2006) Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4. Cell Death Differ. 13, 927-934 (Pubitemid 43753483)
6. Maya, R., Balass, M., Kim, S. T., Shkedy, D., Leal, J. F., Shifman, O., Moas, M., Buschmann, T., Ronai, Z., Shiloh, Y., Kastan, M. B., Katzir, E., and Oren, M. (2001) ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev. 15, 1067-1077
7. Meulmeester, E., Pereg, Y., Shiloh, Y., and Jochemsen, A. G. (2005) ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activation. Cell Cycle 4, 1166-1170
8. Horn, H. F., and Vousden, K. H. (2008) Cooperation between the ribosomal proteins L5 and L11 in the p53 pathway. Oncogene 27, 5774-5784
9. Lowe, S. W., and Sherr, C. J. (2003) Tumor suppression by Ink4a-Arf: progress and puzzles. Curr. Opin. Genet. Dev. 13, 77-83
10. Aylon, Y., Michael, D., Shmueli, A., Yabuta, N., Nojima, H., and Oren, M. (2006) A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization. Genes Dev. 20, 2687-2700
11. Ghosh, S., and Karin, M. (2002) Missing pieces in the NFkappaB puzzle. Cell 109(Suppl.), S81-S96
12. Baeuerle, P. A., and Baltimore, D. (1988) I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 242, 540-546 (Pubitemid 18263193)
13. Verma, I. M., Stevenson, J. K., Schwarz, E. M., Van Antwerp, D., and Miyamoto, S. (1995) Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev. 9, 2723-2735
14. DiDonato, J., Mercurio, F., Rosette, C., Wu-Li, J., Suyang, H., Ghosh, S., and Karin, M. (1996) Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell Biol. 16, 1295-1304
15. Alkalay, I., Yaron, A., Hatzubai, A., Orian, A., Ciechanover, A., and Ben-Neriah, Y. (1995) Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. U. S. A. 92, 10599-10603 (Pubitemid 3009135)
16. Pahl, H. L. (1999) Activators and target genes of Rel/NFkappaB transcription factors. Oncogene 18, 6853-6866
17. Chiao, P. J., Miyamoto, S., and Verma, I. M. (1994) Autoregulation of I kappa B alpha activity. Proc. Natl. Acad. Sci. U. S. A. 91, 28-32
18. Huang, T. T., Wuerzberger-Davis, S. M., Wu, Z. H., and Miyamoto, S. (2003) Sequential modification of NEMO/IKK-gamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 115, 565-576
19. Schwartzenberg-Bar-Yoseph, F., Armoni, M., and Karnieli, E. (2004) The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res. 64, 2627-2633
20. Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N., Nakano, K., Bartrons, R., Gottlieb, E., and Vousden, K. H. (2006) TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126, 107-120
21. Matoba, S., Kang, J. G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., and Hwang, P. M. (2006) p53 regulates mitochondrial respiration. Science 312, 1650-1653
22. Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R., Reese, C. B., and Cohen, P. (1997) Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr. Biol. 7, 261-269
23. Franke, T. F., Kaplan, D. R., Cantley, L. C., and Toker, A. (1997) Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4- bisphosphate. Science 275, 665-668
24. Yang, Z. Z., Tschopp, O., Baudry, A., Dummler, B., Hynx, D., and Hemmings, B. A. (2004) Physiological functions of protein kinase B/Akt. Biochem. Soc. Trans. 32, 350-354
25. Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., and Greenberg, M. E. (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91, 231-241
26. Ogawara, Y., Kishishita, S., Obata, T., Isazawa, Y., Suzuki, T., Tanaka, K., Masuyama, N., and Gotoh, Y. (2002) Akt enhances Mdm2-mediated ubiquitination and degradation of p53. J. Biol. Chem. 277, 21843-21850 (Pubitemid 34952337)
27. Kops, G. J., Medema, R. H., Glassford, J., Essers, M. A., Dijkers, P. F., Coffer, P. J., Lam, E. W., and Burgering, B. M. (2002) Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors. Mol. Cell Biol. 22, 2025-2036
28. Rena, G., Guo, S., Cichy, S. C., Unterman, T. G., and Cohen, P. (1999) Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B. J. Biol. Chem. 274, 17179-17183
29. Tang, E. D., Nunez, G., Barr, F. G., and Guan, K. L. (1999) Negative regulation of the forkhead transcription factor FKHR by Akt. J. Biol. Chem. 274, 16741-16746
30. Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., and Greenberg, M. E. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857-868
31. Bai, D., Ueno, L., and Vogt, P. K. (2009) Akt-mediated regulation of NFkappaB and the essentialness of NFkappaB for the oncogenicity of PI3K and Akt. Int. J. Cancer 125, 2863-2870
32. Honda, R., and Yasuda, H. (1999) Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J. 18, 22-27 (Pubitemid 29005019)
33. Eymin, B., Claverie, P., Salon, C., Leduc, C., Col, E., Brambilla, E., Khochbin, S., and Gazzeri, S. (2006) p14ARF activates a Tip60-dependent and p53-independent ATM/ATR/CHK pathway in response to genotoxic stress. Mol. Cell Biol. 26, 4339-4350
34. Rocha, S., Garrett, M. D., Campbell, K. J., Schumm, K., and Perkins, N. D. (2005) Regulation of NF-kappaB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor. EMBO J. 24, 1157-1169
35. Xia, Y., Padre, R. C., De Mendoza, T. H., Bottero, V., Tergaonkar, V. B., and Verma, I. M. (2009) Phosphorylation of p53 by IkappaB kinase 2 promotes its degradation by beta-TrCP. Proc. Natl. Acad. Sci. U. S. A. 106, 2629-2634
36. Webster, G. A., and Perkins, N. D. (1999) Transcriptional cross talk between NF-kappaB and p53. Mol. Cell. Biol. 19, 3485-3495
37. Ravi, R., Mookerjee, B., van Hensbergen, Y., Bedi, G. C., Giordano, A., El-Deiry, W. S., Fuchs, E. J., and Bedi, A. (1998) p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300. Cancer Res. 58, 4531-4536
38. Marwaha, V., Chen, Y. H., Helms, E., Arad, S., Inoue, H., Bord, E., Kishore, R., Sarkissian, R. D., Gilchrest, B. A., and Goukassian, D. A. (2005) T-oligo treatment decreases constitutive and UVB-induced COX-2 levels through p53- and NFkappaB-dependent repression of the COX-2 promoter. J. Biol. Chem. 280, 32379-32388
39. Wadgaonkar, R., Phelps, K. M., Haque, Z., Williams, A. J., Silverman, E. S., and Collins, T. (1999) CREB-binding protein is a nuclear integrator of nuclear factor-kappaB and p53 signaling. J. Biol. Chem. 274, 1879-1882 (Pubitemid 129621714)
40. Ikeda, A., Sun, X., Li, Y., Zhang, Y., Eckner, R., Doi, T. S., Takahashi, T., Obata, Y., Yoshioka, K., and Yamamoto, K. (2000) p300/CBP-dependent and -independent transcriptional interference between NF-kappaB RelA and p53. Biochem. Biophys. Res. Commun. 272, 375-379
41. Culmsee, C., Siewe, J., Junker, V., Retiounskaia, M., Schwarz, S., Camandola, S., El-Metainy, S., Behnke, H., Mattson, M. P., and Krieglstein, J. (2003) Reciprocal inhibition of p53 and nuclear factor-kappaB transcriptional activities determines cell survival or death in neurons. J. Neurosci. 23, 8586-8595
42. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Jr., Butel, J. S., and Bradley, A. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215-221
43. Komarova, E. A., Krivokrysenko, V., Wang, K., Neznanov, N., Chernov, M. V., Komarov, P. G., Brennan, M. L., Golovkina, T. V., Rokhlin, O. W., Kuprash, D. V., Nedospasov, S. A., Hazen, S. L., Feinstein, E., and Gudkov, A. V. (2005) p53 is a suppressor of inflammatory response in mice. FASEB J. 19, 1030-1032
44. Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B. R., and Kley, N. (1995) Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377, 646-649
45. Feng, Z., Hu, W., de Stanchina, E., Teresky, A. K., Jin, S., Lowe, S., and Levine, A. J. (2007) The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res. 67, 3043-3053
46. Kornfeld, S., Kornfeld, R., Neufeld, E. F., and O'Brien, P. J. (1964) The feedback control of sugar nucleotide biosynthesis in liver. Proc. Natl. Acad. Sci. U. S. A. 52, 371-379
47. Haltiwanger, R. S., Holt, G. D., and Hart, G. W. (1990) Enzymatic addition of O-GlcNAc to nuclear and cytoplasmic proteins. Identification of a uridine diphospho-N-acetylglucosamine: peptide beta-N- acetylglucosaminyltransferase. J. Biol. Chem. 265, 2563-2568
48. Wells, L., Kreppel, L. K., Comer, F. I., Wadzinski, B. E., and Hart, G. W. (2004) O-GlcNAc transferase is in a functional complex with protein phosphatase 1 catalytic subunits. J. Biol. Chem. 279, 38466-38470
49. Yang, W. H., Kim, J. E., Nam, H. W., Ju, J. W., Kim, H. S., Kim, Y. S., and Cho, J. W. (2006) Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. Nat. Cell Biol. 8, 1074-1083
50. Kawauchi, K., Araki, K., Tobiume, K., and Tanaka, N. (2009) Loss of p53 enhances catalytic activity of IKKbeta through O-linked beta-N-acetyl glucosamine modification. Proc. Natl. Acad. Sci. U. S. A. 106, 3431-3436
51. Kawauchi, K., Araki, K., Tobiume, K., and Tanaka, N. (2008) p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation. Nat. Cell Biol. 10, 611-618 (Pubitemid 351627381)
52. Fiordaliso, F., Leri, A., Cesselli, D., Limana, F., Safai, B., Nadal-Ginard, B., Anversa, P., and Kajstura, J. (2001) Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes 50, 2363-2375
53. Yang, W. H., Park, S. Y., Nam, H. W., Kim Do, H., Kang, J. G., Kang, E. S., Kim, Y. S., Lee, H. C., Kim, K. S., and Cho, J. W. (2008) NFkappaB activation is associated with its O-GlcNAcylation state under hyperglycemic conditions. Proc. Natl. Acad. Sci. U. S. A. 105, 17345-17350
54. Michalovitz, D., Halevy, O., and Oren, M. (1991) p53 mutations: gains or losses? J. Cell Biochem. 45, 22-29
55. Dittmer, D., Pati, S., Zambetti, G., Chu, S., Teresky, A. K., Moore, M., Finlay, C., and Levine, A. J. (1993) Gain of function mutations in p53. Nat. Genet. 4, 42-46
56. Pugacheva, E. N., Ivanov, A. V., Kravchenko, J. E., Kopnin, B. P., Levine, A. J., and Chumakov, P. M. (2002) Novel gain of function activity of p53 mutants: activation of the dUTPase gene expression leading to resistance to 5-fluorouracil. Oncogene 21, 4595-4600
57. Sigal, A., and Rotter, V. (2000) Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome. Cancer Res. 60, 6788-6793
58. Lang, G. A., Iwakuma, T., Suh, Y. A., Liu, G., Rao, V. A., Parant, J. M., Valentin-Vega, Y. A., Terzian, T., Caldwell, L. C., Strong, L. C., El-Naggar, A. K., and Lozano, G. (2004) Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. Cell 119, 861-872 (Pubitemid 40017691)
59. Olive, K. P., Tuveson, D. A., Ruhe, Z. C., Yin, B., Willis, N. A., Bronson, R. T., Crowley, D., and Jacks, T. (2004) Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell 119, 847-860 (Pubitemid 40017690)
60. Purdie, C. A., Harrison, D. J., Peter, A., Dobbie, L., White, S., Howie, S. E., Salter, D. M., Bird, C. C., Wyllie, A. H., Hooper, M. L., and Clarke, A. R. (1994) Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene 9, 603-609
61. Weisz, L., Damalas, A., Liontos, M., Karakaidos, P., Fontemaggi, G., Maor-Aloni, R., Kalis, M., Levrero, M., Strano, S., Gorgoulis, V. G., Rotter, V., Blandino, G., and Oren, M. (2007) Mutant p53 enhances nuclear factor kappaB activation by tumor necrosis factor alpha in cancer cells. Cancer Res. 67, 2396-2401